Difference between revisions of "Aspirin and dipyridamole (Aggrenox)"
Jump to navigation
Jump to search
(Created page with "From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of dipyridamole in an extended-release form and 2...") |
m |
||
| Line 6: | Line 6: | ||
[[Category:COX-1 inhibitors]] | [[Category:COX-1 inhibitors]] | ||
[[Category:PDE inhibitors]] | [[Category:PDE inhibitors]] | ||
| + | [[Category:Antipyretics]] | ||
[[Category:Drugs FDA approved in 1999]] | [[Category:Drugs FDA approved in 1999]] | ||
| + | [[Category:FDA approved drugs]] | ||
Revision as of 01:34, 9 October 2017
From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of dipyridamole in an extended-release form and 25 mg of aspirin, as an immediate-release sugar-coated tablet.